May 22, 2024
by Roman Kasianov
News
Sanofi, Formation Bio, and OpenAI have announced a pioneering collaboration aimed at accelerating drug development using artificial intelligence (AI). This …
Jan. 12, 2024
by Basem Goueli MD/PhD/MBA
Biopharma insight
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Aug. 1, 2023
by Andrii Buvailo
Biopharma insight
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that …
Dec. 15, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
Aug. 8, 2022
by BiopharmaTrend
Biopharma insight
(This article was originally published in 2020 and updated in August 2022) Reading life science blogs is a good way …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
May 24, 2021
by Irina Bilous
Biopharma insight
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
Jan. 15, 2021
by Irina Bilous, Andrii Buvailo
Biopharma insight
A decade ago, iPSC (induced Pluripotent Stem Cell) technology was viewed as science fiction. iPSC can be obtained from adult …
Nov. 29, 2020
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
Feb. 21, 2020
by Cathal Strain
Biopharma insight
Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider …
Jan. 28, 2020
by Andrii Buvailo
Interview
Computer-aided drug design (CADD) is a central part of so-called “rational drug design”, pioneered in the last century by companies …
Jan. 2, 2020
by Andrii Buvailo
Biopharma insight
There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …